Ascend Advanced Therapies has received GMP certification for quality control (QC) testing at its site in Munich, Germany. The approval follows a joint inspection conducted by the government of Upper Bavaria and the Paul-Ehrlich-Institute in September 2024. The certification enables Ascend
Ascend Advanced Therapies has partnered with EW Healthcare Partners to enhance its contract manufacturing footprint and capabilities in the United States. As part of the agreement, Advanced BioScience Laboratories (ABL), a CDMO specializing in biotherapy and viral vector production located
Ascend Advanced Therapies has announced a major investment to expand its global infrastructure, targeting growth in its Alachua, Florida, and Munich, Germany facilities. The expansions aim to meet increasing demand in the gene therapy sector. The Alachua facility is undergoing
Ascend Advanced Therapies Contract Manufacturing & Development (CDMO) Profile Ascend Advanced Therapies (Ascend) is a specialist adeno-associated virus (AAV) development partner. In-house Gene to GMP capabilities span from early research, including capsid development and vector optimization, to full scale chemistry,
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
